Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 194,143,127 | $19,406,546,944.00 | 8.7% |
Microsoft Corp. | Equity | 24,566,899 | $10,335,785,747.00 | 4.63% |
Broadcom, Inc. | Equity | 7,605,398 | $10,080,270,563.00 | 4.52% |
Capital Group Central Corporate Bond Fund | Investment Fund | 802,783,018 | $6,711,266,029.00 | 3.01% |
Meta Platforms, Inc., Class A | Equity | 7,757,181 | $3,766,731,950.00 | 1.69% |
Philip Morris International, Inc. | Equity | 40,872,199 | $3,744,710,872.00 | 1.68% |
UnitedHealth Group, Inc. | Equity | 7,551,038 | $3,735,498,499.00 | 1.67% |
Eli Lilly and Co. | Equity | 4,524,666 | $3,520,009,161.00 | 1.58% |
Alphabet, Inc., Class C | Equity | 22,144,097 | $3,371,660,209.00 | 1.51% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 23,691,787 | $3,223,267,621.00 | 1.44% |
Home Depot, Inc. | Equity | 8,150,079 | $3,126,370,304.00 | 1.4% |
JPMorgan Chase & Co. | Equity | 14,401,718 | $2,884,664,115.00 | 1.29% |
General Electric Co. | Equity | 13,953,860 | $2,449,321,046.00 | 1.1% |
Canadian Natural Resources, Ltd. | Equity | 31,851,146 | $2,429,721,248.00 | 1.09% |
Vertex Pharmaceuticals, Inc. | Equity | 4,178,090 | $1,746,483,401.00 | 0.78% |